Security and asset marking COVID-19 Corporate/Financial News Printing and Packaging Government and Military Personal care Pharmaceuticals
LineaRx Licenses CAR T Drug Candidate, Initiates Pre-Clinical Development of Non-viral, Plasmid-free CAR T Manufacturing Platform
October 16, 2018
LineaRx Secures New RNA Therapeutics Customers for Contract Research Services
October 1, 2018
Applied DNA Expands Its Cannabis Tagging Portfolio to Address Large Growers
September 25, 2018
Applied DNA Subsidiary, LineaRx, Inc. Signs Joint Development Agreement with Takis and Evvivax to Develop Linear-DNA Based Anti-Cancer Vaccines
September 20, 2018
APDN Executes New 2 Year Contract with the U.S. Defense Logistics Agency
September 11, 2018
Applied DNA Announces $1.65 Million Private Placement of Secured Convertible Notes
September 4, 2018
Get Social